ED50: <0.4 µg/ml, as determined by its ability to inhibit IGF-II induced proliferation of MCF-7. The expected ED50 for this effect, corresponding to a specific activity of >2500 IU/mg in the presence of 15 ng/ml of rHuIGF-II.
Purity
>96% as determined by RP-HPLC and SDS-PAGE.
Product Form
Lyophilized
Concentration
1 mg/ml
Formulation
Lyophilized from 10 mM Sodium Citrate Buffer, pH 3.
Storage
Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.
Synonyms
IBP-5, IBP5, IGF-binding protein 5, IGFBP-5, Insulin-like growth factor-binding protein 5
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Human IGFBP5 Protein (A63260)? Please let us know so that we can list the citation on this page.
Proteins predicted to interact with IGFBP5
Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
